How to buy Hologic (HOLX) stocks

Hologic is a medical instruments & supplies business based in the US. Hologic shares (HOLX) are listed on the NASDAQ and all prices are listed in US Dollars.

Its last market close was $61.10 – a decrease of 2.24% over the previous week. Hologic employs 7,063 staff and has a trailing 12-month revenue of around $4 billion.

Our top picks for where to buy Hologic stock

Buy Hologic stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Note: The dollar amounts in the table below are in Canadian dollars.

Finder Score for stock trading platforms

To make comparing even easier we came up with the Finder Score. Trading costs, account fees and features across 10+ stock trading platforms and apps are all weighted and scaled to produce a score out of 10. The higher the score the better the platform - simple.

Read the full methodology

Related: Compare the best stock trading platforms in Canada

Hologic stock price (NASDAQ: HOLX)

Use our graph to track the performance of HOLX stocks over time.

Hologic stocks at a glance

• Key figures

Information last updated 2025-03-06.

Latest market close	$61.10
52-week range	$61.70 - $84.67
50-day moving average more info button	$68.75
200-day moving average more info button	$75.91
Wall St. target price	$79.91
PE ratio more info button	19.7785
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$3.16

Is it a good time to buy Hologic stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Dive deeper: Our picks for the best stocks to buy right now in Canada

Hologic price performance over time

Historical closes compared with the close of $62.59 from 2025-03-11

1 week (2025-03-06)	0.14%
1 month (2025-02-13)	-1.62%
3 months (2024-12-13)	-15.02%
6 months (2024-09-13)	-22.87%

1 year (2024-03-13)	-18.00%
2 years (2023-03-13)	-20.06%
3 years (2022-03-11)	69.44
5 years (2020-03-13)	54.24%

Is Hologic stock undervalued or overvalued?

Valuing Hologic stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Hologic's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Hologic's P/E ratio

Hologic's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 20x. In other words, Hologic shares trade at around 20x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the stock or simply that they're under-valued.

Hologic's PEG ratio

Hologic's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.3649. A low ratio can be interpreted as meaning the stocks offer better value, while a higher ratio can be interpreted as meaning the stocks offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Hologic's future profitability. By accounting for growth, it could also help you if you're comparing the stock prices of multiple high-growth companies.

Hologic's EBITDA

Hologic's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $1.3 billion.

The EBITDA is a measure of a Hologic's overall financial performance and is widely used to measure a its profitability.

Hologic financials

Revenue TTM	$4 billion
Operating margin TTM	22.87%
Gross profit TTM	$2.5 billion
Return on assets TTM	7.1%
Return on equity TTM	15.78%
Profit margin	18.42%
Book value	$21.16
Market Capitalization more info button	$14.1 billion

TTM: trailing 12 months

Hologic stock dividends

We're not expecting Hologic to pay a dividend over the next 12 months.

Have Hologic's stocks ever split?

Hologic's stocks were split on a 2:1 basis on 2 April 2008 . So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Hologic stocks – just the quantity. However, indirectly, the new 50% lower stock price could have impacted the market appetite for Hologic stocks, which in turn could have impacted Hologic's stock price.

Hologic stock price volatility

Over the last 12 months, Hologic's stocks have ranged in value from as little as $61.7 up to $84.67. A popular way to gauge a stock's volatility is its "beta."

Beta is a measure of a stocks volatility in relation to the market. The market (NASDAQ average) beta is 1, while Hologic's is 0.975. This would suggest that Hologic's stocks are less volatile than average (for this exchange).

Hologic overview

Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment worldwide. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginosis and candida vaginitis assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays to detect SARS-CoV-2; ThinPrep System for cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. The company also offers breast cancer care solutions in the areas of radiology, breast surgery, pathology, and treatment, such as 3D digital mammography systems, image analytics software, reading workstations, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, and specimen radiology solutions; and breast conserving surgery products. In addition, it provides MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids and polyps in the uterus; NovaSure Endometrial Ablation System to treat abnormal uterine bleeding; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; Acessa ProVu system to treat various fibroids; and CoolSeal portfolio, such as bipolar vessel sealing devices. Further, it offers Horizon DXA, a dual energy X-ray system; and Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures.

Related: New to stock trading? Compare brokers and get tips for investing.

Frequently asked questions

What percentage of Hologic is owned by insiders or institutions?
Currently 1.013% of Hologic stocks are held by insiders and 105.103% by institutions. How many people work for Hologic?
Latest data suggests 7,063 work at Hologic. When does the fiscal year end for Hologic?
Hologic's fiscal year ends in September. Where is Hologic based?
Hologic's address is: 250 Campus Drive, Marlborough, MA, United States, 01752 What is Hologic's ISIN number?
Hologic's international securities identification number is: US4364401012 What is Hologic's CUSIP number?
Hologic's Committee on Uniform Securities Identification Procedures number is: 436440101

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.